| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.3 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |